BlackRock Amends West Pharma Stake, Signals Updated Position
Ticker: WST · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 105770
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock updated its stake in West Pharma; keep an eye on institutional sentiment.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, indicating its ownership of Common Stock in West Pharmaceutical Services Inc. as of December 31, 2023. This filing is an amendment, meaning BlackRock previously reported its stake and is now updating that information. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal its confidence (or lack thereof) in West Pharmaceutical Services Inc.'s future prospects.
Why It Matters
This filing shows BlackRock's updated position in West Pharmaceutical Services Inc., which can influence investor sentiment and potentially the stock's trading activity.
Risk Assessment
Risk Level: low — This is a routine amendment filing by a large institutional investor and does not inherently signal significant risk.
Analyst Insight
Investors should monitor subsequent filings from BlackRock to see if their stake in West Pharmaceutical Services Inc. significantly increases or decreases, as this could indicate a shift in their investment thesis.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- West Pharmaceutical Services Inc. (company) — the subject company whose securities are being reported
- January 24, 2024 (date) — the filing date of the SC 13G/A
- December 31, 2023 (date) — the date of the event which required the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and '(Amendment No: 1)' in the filing.
Who is the subject company of this filing?
The subject company is WEST PHARMACEUTICAL SERVICES INC, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC'.
Who is the entity that filed this SC 13G/A?
The entity that filed this SC 13G/A is BlackRock Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.'.
What is the CUSIP number for the securities reported in this filing?
The CUSIP number for the Common Stock of West Pharmaceutical Services Inc. is 955306105, as listed under '(CUSIP Number)'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as specified in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding WEST PHARMACEUTICAL SERVICES INC (WST).